A family says a drug company led them to believe that their 16-year-old son could participate in a clinical trial for an experimental muscular dystrophy drug, but then went back on its word.
20
2:22
August '08
A family says a drug company led them to believe that their 16-year-old son could participate in a clinical trial for an experimental muscular dystrophy drug, but then went back on its word.